University of Sheffield:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University of Sheffield - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9291
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Sheffield (Sheffield University) is an educational service provider that offers undergraduate, postgraduate, research and certificate programmes. The university offers courses in various fields including arts and humanities, engineering, medicine, dentistry and health; social sciences. It also provides courses in the areas of accounting and financial management, civil and structural engineering, computer science, human communication sciences, neuroscience, biomedical science, automatic control and systems engineering, town and regional planning, among others. The university conducts various research and development activities. Sheffield University is headquartered in Sheffield, the UK.

University of Sheffield – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University of Sheffield, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
University of Sheffield, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mironid Enters into Co-Development Agreement with University of Sheffield 10
Diurnal Enters into Research Agreement with University of Sheffield 11
MedImmune Enters into Research Agreement with University of Sheffield 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Licensing Agreements 14
Diurnal Enters into Licensing Agreement with University of Sheffield for Oligonucleotide Therapy 14
University of Sheffield – Key Competitors 15
University of Sheffield – Key Employees 16
University of Sheffield – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
Aug 31, 2018: Liver disease drug could help restore cells damaged by Alzheimer’s 18
Aug 14, 2018: Alternative patient-controlled pain relief drug could significantly reduce the number of epidurals 20
Aug 03, 2018: Stem cell transplants to be used in treating Crohn’s disease 22
Jul 24, 2018: Ground breaking research into rare bone cancer funded by inspirational legacy 24
May 21, 2018: Sheffield scientists get £150K boost for pioneering dementia research 25
May 21, 2018: Our scientists receive £150,000 boost for pioneering dementia research 26
May 08, 2018: New study to investigate premedication combating children’s anxiety prior to general anaesthesia 27
Oct 22, 2017: Novel therapies for multi drug-resistant bacteria 29
Sep 05, 2017: Acceptance and Commitment Therapy for people with motor neuron disease 30
Jul 14, 2017: New gene therapy treatment routes for motor neurone disease uncovered in new University of Sheffield study 31
Other Significant Developments 32
Jul 06, 2018: Computer therapy can help people with aphasia find lost words 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
University of Sheffield, Pharmaceuticals & Healthcare, Key Facts 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Deals By Therapy Area, 2012 to YTD 2018 8
University of Sheffield, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mironid Enters into Co-Development Agreement with University of Sheffield 10
Diurnal Enters into Research Agreement with University of Sheffield 11
MedImmune Enters into Research Agreement with University of Sheffield 12
Blueberry Therapeutics Enters into Agreement with University of Sheffield and Sheffield Hallam University 13
Diurnal Enters into Licensing Agreement with University of Sheffield for Oligonucleotide Therapy 14
University of Sheffield, Key Competitors 15
University of Sheffield, Key Employees 16
University of Sheffield, Subsidiaries 17

List of Figures
University of Sheffield, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University of Sheffield, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University of Sheffield, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[University of Sheffield:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vergnet SA (ALVER)-エネルギー分野:企業M&A・提携分析
    Summary Vergnet SA (Vergnet) is a renewable energy company. It designs, develops, and manufactures renewable solutions. The company offers wind, solar and hybrid energy solutions besides solar applications. Through its technology Hybrid Wizard, Vergnet offers real-time hybrid controller solutions fo …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hino Motors, Ltd.:企業の戦略・SWOT・財務情報
    Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Hino Motors, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Foundation Radiology Group PC-医療機器分野:企業M&A・提携分析
    Summary Foundation Radiology Group PC (FRG) is a radiology solutions provider. The company provides radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It provides imaging solutions for the radiologists and system …
  • Bank AlJazira:企業の戦略・SWOT・財務情報
    Bank AlJazira - Strategy, SWOT and Corporate Finance Report Summary Bank AlJazira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Okamoto Industries, Inc.
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Opsens Inc (OPS):企業の財務・戦略的SWOT分析
    Summary Opsens Inc (Opsens), formerly DCB Capital Inc, is a provider of fiber optic sensing technology solutions. It focuses on fractional flow reverse guidewire in interventional cardiology. It offers OptoWire, an optical-based pressure guidewire, which enhances the clinical outcome of patients wit …
  • Synaxon AG:企業の戦略的SWOT分析
    Synaxon AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Wien Energie GmbH:企業の戦略的SWOT分析
    Wien Energie GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Ws Atkins Ltd
    Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report Summary Ws Atkins Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Imperial Metals Corporation:企業の戦略・SWOT・財務情報
    Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report Summary Imperial Metals Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Greensmith Energy Management Systems LLC-エネルギー分野:企業M&A・提携分析
    Summary Greensmith Energy Management Systems, LLC (Greensmith) is a provider of energy storage management and services. The company specializes in software and control solutions to operate and manage Distributed Energy Storage Systems (DESS) for utility-scale, C&I or Micro-grid deployments. It offer …
  • Copperbelt Energy Corporation Plc (CEC):企業の財務・戦略的SWOT分析
    Copperbelt Energy Corporation Plc (CEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • John Wiley & Sons, Inc.:企業のM&A・事業提携・投資動向
    John Wiley & Sons, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's John Wiley & Sons, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Rubis SCA (RUI):企業の財務・戦略的SWOT分析
    Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • XERIS Pharmaceuticals Inc (XERS):医療機器:M&Aディール及び事業提携情報
    Summary XERIS Pharmaceuticals Inc (XERIS) is a specialty pharmaceutical company that develops and commercializes injectable and infusible drug formulations. The company’s proprietary XeriSol and XeriJect formulation technologies allow for the subcutaneous and intramuscular delivery of ultra concentr …
  • Mahle GmbH:企業の戦略的SWOT分析
    Mahle GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Mylan Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mylan Pharmaceuticals Pvt Ltd (Mylan), a subsidiary of Mylan NV, is a pharmaceutical company that manufactures generic, speciality and active pharmaceutical ingredients (API). The company provides products such as critical care products, hepato care products, HIV care products, onco care pro …
  • Tokyo Electric Power Company Holdings Incorporated (9501)-エネルギー分野:企業M&A・提携分析
    Summary Tokyo Electric Power Company Holdings, Incorporated (TEPCO), formerly Tokyo Electric Power Company, Incorporated, is an integrated energy company. The company generates, transmits, distributes and sells electricity through its subsidiaries. It generates power from various sources such as the …
  • Oil India Ltd (OIL):企業の財務・戦略的SWOT分析
    Oil India Ltd (OIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆